AllQuantitative Report
logoArgus•February 17, 2021

ANIP: Lowering target price to $25.00

Symbols
ANIP
Sector(s)
Healthcare
Rating
Current Price
$64.58
Price Target
Earnings Estimate
Summary

ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Actions

Download Full Report

Related Reports

View more related reports